The Global Impact of Blood Cancer

This infographic represents the annual diagnoses, mortality, and survival rates of individuals with blood cancer.

Scopio supports hematologists, hematopathologists, and laboratory professionals around the world. 

  • Every 3 minutes, someone in the U.S. is diagnosed with blood cancer, and more than 1.3 million Americans are living with the disease or in remission.
  • An estimated 1.24 million people worldwide are diagnosed with the disease annually, accounting for approximately 6% of all cancer cases. 
  • Worldwide, approximately 720,000 people die from the disease every year, accounting for more than 7% of cancer deaths. 
  • Survival rates increase significantly when cancer is identified at early stages; average 5-year survival at early stage is 91%, while average 5-year survival at late stage is 26%.
  • The large variability, associated risk factors and multiple early symptoms make these cancers difficult to detect. A major challenge for treatment is the lack of early detection testing. 
  • The average 5-year survival rate of Non-Hodgkin Lymphoma is 64%, but this number rises to 74% when identified in the localized (early) stage.

Sources:

  1. https://www.lls.org/article/september-blood-cancer-awareness-month
  2. https://www.bms.com/assets/bms/us/en-us/pdf/Disease-State-Info/blood-cancers-at-a-glance.pdf
  3. https://www.bms.com/assets/bms/us/en-us/pdf/Disease-State-Info/blood-cancers-at-a-glance.pdf
  4. https://www.nature.com/articles/s41467-020-17316-z#:~:text=Survival%20rates%20increase%20significantly%20when,late%20stage%20is%2026%254
  5. https://audubonbio.com/blog/blood-cancers-overview-advancements-and-challenges/#:~:text=A%20major%20challenge%20for%20blood,development%20of%20AML%20and%20ALL
  6. https://www.cancer.org/cancer/non-hodgkin-lymphoma/detection-diagnosis-staging/factors-prognosis.html
  7. https://scopiolabs.com/